Get the Stockscreener App
1.31
5.07%
-0.07
Pre-market:
1.33
0.02
+1.53%
Bluejay Diagnostics Inc stock is traded at $1.31, with a volume of 361.94K.
It is down -5.07% in the last 24 hours and down -18.63% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
See More
Previous Close:
$1.38
Open:
$1.34
24h Volume:
361.94K
Relative Volume:
0.17
Market Cap:
$1.96M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.000954
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
-10.88%
1M Performance:
-18.63%
6M Performance:
-63.50%
1Y Performance:
-91.20%
1-Day Range:
$1.26
$1.40
1-Week Range:
$1.26
$2.48
52-Week Range:
$1.26
$18.25
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.31 | 2.06M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
129.28 | 225.22B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.15 | 151.88B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.52 | 144.88B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.98 | 119.04B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.18 | 45.61B | 5.69B | 1.41B | 577.90M | 6.95 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Visualizing Bluejay Diagnostics Inc. stock with heatmapsSwing Trade & Free Reliable Trade Execution Plans - Newser
Will Bluejay Diagnostics Inc. benefit from macro trendsWeekly Volume Report & Weekly Breakout Opportunity Watchlist - Newser
Automated trading signals detected on Bluejay Diagnostics Inc.2025 Technical Patterns & Fast Entry High Yield Tips - Newser
Sentiment analysis tools applied to Bluejay Diagnostics Inc.2025 Top Gainers & High Win Rate Trade Tips - Newser
Why Bluejay Diagnostics Inc. stock attracts strong analyst attentionJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Bluejay Diagnostics Inc. stock chart pattern explained2025 Price Momentum & High Return Stock Watch Alerts - Newser
Detecting support and resistance levels for Bluejay Diagnostics Inc.2025 Historical Comparison & Consistent Growth Stock Picks - Newser
Applying Elliott Wave Theory to Bluejay Diagnostics Inc.Weekly Stock Recap & Daily Profit Maximizing Tips - Newser
Chart based analysis of Bluejay Diagnostics Inc. trendsShare Buyback & Low Drawdown Momentum Ideas - Newser
What Fibonacci levels say about Bluejay Diagnostics Inc. reboundJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
What makes Bluejay Diagnostics Inc. stock price move sharplyFree Fundamental Growth Stock Analysis - Newser
Will breakout in Bluejay Diagnostics Inc. lead to full recoveryFree Fast Exit and Entry Strategy Guide - Newser
Bluejay Diagnostics (BJDX.O): Unraveling the Sudden Intraday Drop - AInvest
Bluejay Diagnostics Plunges 19.7%: What’s Behind the Sharp Intraday Drop? - AInvest
Penny Stock Watchlist: Equillium, Bluejay Diagnostics, and Entero Therapeutics - AInvest
Bluejay Diagnostics Plunges 21%: What's Behind the Sharp Intraday Drop? - AInvest
Why Did Bluejay Diagnostics Plunge 14.89% After Surge? - AInvest
Leading vs lagging indicators on Bluejay Diagnostics Inc. performanceStrategy Builder for Growth Focused Traders - Newser
What moving averages say about Bluejay Diagnostics Inc.Buy Zone Strategy with Pattern Recognition - Newser
Analyzing Bluejay Diagnostics Inc. with multi timeframe chartsTrade Plan With Low Risk High Return - Newser
Is This a Bottoming Phase for Bluejay Diagnostics Inc.Entry Points For Growing Stocks Identified by Models - beatles.ru
Bluejay Diagnostics Soars 63.57% on Q2 Catalysts and Strategic Manufacturing Shifts - AInvest
Bluejay Diagnostics Surges 43% Amid Sector-Wide Tech Breakthroughs—What’s Fueling the Frenzy? - AInvest
Bluejay’s New Gains: Analyzing the Uptick - StocksToTrade
BJDX Soars After Promising Q2 Update - timothysykes.com
Bluejay Diagnostics Stock Soars 12.86% on Bullish Analyst Sentiment - AInvest
Head to Head Survey: Treace Medical Concepts (NASDAQ:TMCI) versus Bluejay Diagnostics (NASDAQ:BJDX) - Defense World
Real time social sentiment graph for Bluejay Diagnostics Inc.Market Forecast Summary Over Multi-Year Period - Newser
Detecting price anomalies in Bluejay Diagnostics Inc. with AIFree Opportunity Map for Daily Stock Trading - Newser
Volatility clustering patterns for Bluejay Diagnostics Inc.Buy and Hold Return Summary with Charts - Newser
Is Bluejay Diagnostics Inc. forming a bottoming baseEarly Entry Planner for Swing Candidates - Newser
Quantitative breakdown of Bluejay Diagnostics Inc. recent moveMulti-Year Signal Summary and Entry Timing - Newser
Measuring Bluejay Diagnostics Inc.’s beta against major indicesFree Low Volatility Stable Growth Picks - Newser
Bluejay Diagnostics' Strategic Progress in Sepsis Diagnostics and Manufacturing Readiness: A Catalyst for Regulatory Clearance and Shareholder Value - AInvest
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update - The Manila Times
Bluejay Diagnostics Reports Q2 Business Update, SYMON-II Clinical Trial Underway - AInvest
Bluejay's Game-Changing Sepsis Detection Trial Progresses as Company Raises Fresh Capital - Stock Titan
Sintx Technologies (NASDAQ:SINT) versus Bluejay Diagnostics (NASDAQ:BJDX) Financial Contrast - Defense World
Is Bluejay Diagnostics Inc. still worth holding after the dipHigh Win Rate Strategy with Stop Protection - Newser
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):